SAMA Schultze Special Purpose Acquisition

Clever Leaves Partners With House of Kush for International Expansion

Clever Leaves Partners With House of Kush for International Expansion

Multinational operator partners with House of Kush to grow and commercialize THC smokable flower from House of Kush’s genetics outside of the United States and Canada

TOCANCIPÁ, Colombia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced a partnership today with U.S. cannabis-branded genetic innovation company, House of Kush, to be the exclusive grower and distributor of proprietary genetics globally. Clever Leaves will be the exclusive producer of various genetics for House of Kush outside of the United States and Canada.

As the exclusive grower for House of Kush globally, Clever Leaves will cultivate and commercialize House of Kush proprietary genetics in its Colombia and Portugal facilities for the duration of the three-year agreement, after completing an initial evaluation and adaptation phase of the genetics for each production location. This partnership will further strengthen Clever Leaves’ portfolio of high THC smokable flower which is already being sold in Germany, Israel, and Australia.

Clever Leaves will produce various House of Kush strains including Bubba Kush Pre-98 and San Fernando Valley OG Kush in Clever Leaves’ Colombia and Portugal facilities. In Colombia, the company operates 18 hectares of cultivation and has received multiple international certifications including European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute – Invima, and Good Agricultural and Collection Practices (GACP) Certification. Clever Leaves’ Portugal facility is located on approximately nine million square feet of land, consists of approximately 260,000 square feet of greenhouse facilities, and was granted a license from INFARMED I.P., the Portuguese regulatory authority with oversight over the pharmaceutical industry in Portugal, for importing, exporting, and cultivating cannabis, (EU GMP) certification and are (GACP) certified.

Andres Fajardo, Clever Leaves’ CEO, stated, “The strategic partnership with House of Kush leverages both companies core capabilities. On the one hand, it will allow Clever Leaves to further expand its flower portfolio with globally renowned genetics. On the other hand, it will serve as a platform for House of Kush to expand their coverage beyond the United States and Canada. Together we will be able to bring high quality product to patients at a global level on a consistent basis.”

Steve Gardner, co-founder of House of Kush, said, “This agreement expands our market presence beyond America in a meaningful and significant way. By working with a global leader in Clever Leaves, this enables us to deliver our legacy genetics to customers around the world who want to incorporate some of the all-time great strains into their routines. We will bring strains people recognize with a brand they can trust for product consistency.”

Clever Leaves and House of Kush will work together to develop the proper cultivation protocols to best meet those required by the different genetics. The strains being grown will be offered to Clever Leaves customers globally, through the Company’s sales and distribution channels, and depending on specific business strategies House of Kush might provide marketing and sales support or extend the participation in co-branding efforts.

About Clever Leaves Holdings Inc.

Clever Leaves is a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids. Its operations in Colombia and Portugal produce cannabinoid active pharmaceutical ingredients (API) and finished products ​in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods, with the world’s most stringent pharmaceutical quality certifications. For more information, please visit  and follow Clever Leaves on Twitter and LinkedIn.

About House of Kush

House of Kush is a leading legacy genetics cannabis company based in the United States. They currently have partners in eight states, with several more being added in 2023. As a majority Black-owned business, House of Kush has a social equity strategy that includes developing economic opportunity in Black and brown communities across the country. They offer a customized portfolio of products in each state backed by the ‘Kush Certified’ logo, guaranteeing customers are getting the legitimate legacy product. As a company, they are dedicated to high-quality products with sustainably focused partners. For more information, please visit and follow Kush Certified on FB, LI and Instagram.

Press Contacts:

Rich DiGregorio

KCSA Strategic Communications



Diana Sigüenza

Strategic Communications Director

0

Clever Leaves Commercial Inquiries:

Andrew Miller

Head of Business Development



House of Kush Media Relations:

Rob Wheat



Clever Leaves Investor Inquiries:

Cody Slach and Jackie Keshner

Gateway Group, Inc.





EN
21/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Schultze Special Purpose Acquisition

 PRESS RELEASE

Clever Leaves Announces Voluntary Delisting and SEC Deregistration

Clever Leaves Announces Voluntary Delisting and SEC Deregistration TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that its Board of Directors (the “Board”) determined to voluntarily delist its common shares, without par value (the “common shares”) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the “Warrants” and together with the common shares, the “Securities”) from The Nasdaq Stock Market LLC (“Nasdaq”...

 PRESS RELEASE

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results - 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year - - Completed Sale of Non-Cannabinoid Herbal Brands Business on March 21, 2024 for $8.02 Million, Including $7.02 Million in Cash Paid at Closing - TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabi...

 PRESS RELEASE

Clever Leaves and Paradise Seeds to Develop and Register Genetic Asset...

Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to develop and register high performance cannabis cultivars in Colombia, Clever Leaves will have exclusive license to cultivate some of these genetics, while Paradise will make other cultivars available to third parties for...

 PRESS RELEASE

Clever Leaves Granted Australian GMP Certification for Cannabis Produc...

Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA) Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products. Clever Leaves is the first and only medicinal cannabis company globally that has GMP certifications from the European Union, Colombia, Brazil and Australia. TOCANCIPÁ, Colombia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that it has been granted Australia...

 PRESS RELEASE

Clever Leaves Reports Third Quarter 2023 Results

Clever Leaves Reports Third Quarter 2023 Results - Q3 Revenue Increased 33% Year-Over-Year, Propelled by 135% Year-Over-Year Growth in Cannabinoid Revenue, Along with 6% Year-Over-Year Growth in Non-Cannabinoid Revenue - - Q3 Adjusted EBITDA Improved Year-Over-Year to $(2.6) Million Compared to $(3.7) Million, Reflecting Revenue Growth and Continued Aggressive Expense Reductions - - Cash Balance at October 31, 2023 was $6.2 Million, with $1.9 Million in Subsequent Capital Received from the November Sale of the Company’s Remaining Stake in Cansativa - - Updated Full Ye...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch